Therefore, we suggest that scabertopin can downregulate the expression of MMP-9 by inhibiting the activation of the FAK/PI3K/Akt signaling axis and, ultimately, inhibit the invasiveness of bladder cancer cells. This evidence concerns the gene MMP9 and urinary bladder carcinoma.